Medtech Companies Must Adjust To Growth Of Outpatient Centers, ZS Consultant Advises
The medtech industry has been slow to adapt to the rapid growth of lower-cost outpatient centers that are taking procedures out of hospitals, according to Brian Chapman, a consultant for ZS.
You may also be interested in...
Medtech CEOs Predict Diminished Role For Hospitals In The Future Of Surgery
Surgical volumes are rebounding close to pre-pandemic levels, but the volumes at hospitals may never completely rebound, according to medtech CEOs participating in a discussion at The Virtual MedTech Conference.
Interview: How Medtech Companies Are Preparing To Navigate Post-Pandemic Market
In an interview with Medtech Insight, ZS consultant Brian Chapman explains how medtech companies are handling the uncertainties created by the pandemic and how it could change the industry permanently.
Medtech Giants Ready To Battle Frontrunner Intuitive Surgical In 'Soft Surgery Robotics'
The global market for robotic surgery systems is expected to reach $9.7bn by 2023. With medtech giants Medtronic, Johnson & Johnson and Zimmer Biomet launching robotic platforms in 2020, this market is set for a major shakeup.